Development and validation of a high-performance liquid chromatographic method for bioanalytical application with rimonabant

Journal of Pharmaceutical and Biomedical Analysis

Volumn 49, Issue 4, 2009, Pages 1009-1013

  Bhaumik, Uttam ^a   Ghosh, Animesh ^a   Chatterjee, Bappaditya ^a   Sengupta, Pinaki ^a   Darbar, Soumendra ^a   Roy, Bikash ^a   Nandi, Utpal ^a   Pal, Tapan K ^a  

^a JADAVPUR UNIVERSITY   (India)

Author keywords

High performance liquid chromatography; Plasma analysis; Rimonabant; Validation

Indexed keywords

GLIMEPIRIDE; RIMONABANT;

ACCURACY; ADULT; ARTICLE; BIOEQUIVALENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG DETERMINATION; DRUG HALF LIFE; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; VOLUNTEER;

ADULT; ANTI-OBESITY AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; INDICATORS AND REAGENTS; MALE; PIPERIDINES; PYRAZOLES; QUALITY CONTROL; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLUTIONS; SPECTROPHOTOMETRY, ULTRAVIOLET; THERAPEUTIC EQUIVALENCY; YOUNG ADULT;

EID: 62749155288     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.01.032     Document Type: Article

References (18)

1. Carai M., Colombo G., and Gessa G.L. Life. Sci. 77 (2005) 2339-2350
2. Patel P.N., and Pathak R.A. J. Health-Syst. Pharm. 64 (2007) 481-489
3. Rinaldi M.C., Barth F., Heauime M., Shire D., Calandra B., Congy C., Aartinez S., Maruani J., Neliat G., Caput D., Ferra P., Soubrie P., Breliere J.C., and Le G. FEBS Lett. 350 (1994) 240-244
4. Padwal R.S., and Majumdar S.R. Lancet 369 (2007) 71-77
5. Pi-Sunyer F.X., Aronne L.J., Heshmati H.M., Devin J., and Rosenstock J. JAMA 295 (2006) 761-775
6. Pertwee R.G. Pharmacol. Ther. 74 (1997) 129-180
7. McAllister S.D., Griffin G., Satin L.S., and Abood M.E. J. Pharmacol. Exp. Ther. 291 (1999) 618-626
8. Felder C.C., Joyce K.E., Briley E.M., Mansouri J., Mackie K., Blond O., Lai Y., Ma A.L., and Mitchell R.L. Mol. Pharmacol. 48 (1995) 443-450
9. Bouaboula M., Poinot-Chazel C., Bourrie B., Canat X., Calandra B., Rinaldi-Carmona M., Le Fur G., and Casellas P. Biochem. J. 312 (1995) 637-641
10. Navarro M., Carrera M., Fratta W., Valverde O., Cossu G., Fattore L., Chowen J.A., Gomez R., Villanua M., Maldonado R., Koob G., and Rodriguez de Fonseca F. J. Neurosci. 21 (2001) 5344-5350
11. Vries T.D., Shaham Y., Homberg J., Crombag H., Schuurman K., Dieben J., Vanderschuren L., and Schoffelmeer A. Nat. Med. 7 (2001) 1151-1154
12. Nirogi R., Kandikere V., Mudigonda K., and Ajjala D. Biomed. Chromatogr. 22 (2008) 469-477
13. McCulloch M., Zhou X., Xu Y., Brunell S., and Spear L. J. Chromatogr. B 863 (2008) 258-265
14. Hsieh Y., Duncan C.J.G., and Brisson J.M. Anal. Chem. 79 (2007) 5668-5673
15. Food and Drug Administration of the United States, Guidance for Industry-Bioanalytical Method Validation, U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), May 2001 (http://www.fda.gov/cder/guidance/index.htm).
16. Nehal L.J., Alex S., William D.L., Jurgen V., and William F.D. J. Chromatogr. B 806 (2004) 289-293
17. Bhaumik U., Ghosh A., Sarkar A.K., Bose A., Selvan P.S., Sengupta P., Chakraborty U.S., Ghosh D., and Pal T.K. J. Pharm. Biomed. Anal. 48 (2008) 1404-1410
18. Delyle S.G., Abe E., Devillier P., and Alvarez J.C. J. Chromatogr. B 872 (2008) 115-120